Activity ID
11179Expires
October 3, 2026Format Type
EnduringCME Credit
0.5Fee
$30CME Provider: American Medical Association
Description of CME Course
As the United States is experiencing an unprecedented drug-related overdose epidemic, there are steps we can take to prevent them. In this episode, we’ll discuss overdose prevention strategies, including the benefits of naloxone for opioid-related overdose prevention. We’ll also take a look at ways to reduce stigma and bias related to overdose prevention.
After listening to this podcast, please take a moment to fill out SAMHSA’s Post-Event survey: Post-Event Survey
Funding for this initiative was made possible (in part) by grant no. 6H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the US Government.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Allergy and Immunology
Anesthesiology
Colon and Rectal Surgery
Family Medicine
Medical Genetics and Genomics
Nuclear Medicine
Ophthalmology
Orthopaedic Surgery
Pathology
Physical Medicine and Rehabilitation
Plastic Surgery
Preventive Medicine
Psychiatry and Neurology
Radiology
Thoracic Surgery
Urology
Commercial Support?
NoNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
1. Describe opioid overdose prevention strategies
2. Explain the benefits of naloxone for opioid overdose prevention
3. Recognize ways to reduce stigma and bias related to opioid overdose prevention
Keywords
Opioids, Substance Use and Addiction Medicine, Toxicology
Competencies
Medical Knowledge
CME Credit Type
AMA PRA Category 1 Credit
DOI
10.1001/ama.2022.0002041
